Of these 11 datasets, 7 profiled the phosphoproteome of non-small cell lung carcinoma (NSCLC) cell lines with activating mutations in EGFR (H3255 and HCC827)23,45–48 and 4 datasets profiled K562 cells, a chronic myeloid leukemia (CML) cell line containing the BCR-ABL fusion protein23,34,44. This evidence concerns the gene ABL1 and non-small cell lung carcinoma.